The Ketamine Taskforce
is a 100% volunteer based organization committed to increasing safe care, accessibility, education, and insurance coverage for all Veterans, First Responders, Health Professionals, and anyone in need.
Our Mission Statement
The Ketamine Taskforce is committed to ensuring that individuals affected by chronic pain and mental health conditions have access to ketamine's proven therapeutic benefits.
We advocate for approval by insurance companies, TRICARE, the VA, and Medicare to cover the cost of ketamine infusions, while ensuring fair reimbursement rates for providers.
A core part of our mission is to advance public awareness and education around ketamine therapy, helping to reduce the lingering stigma associated with its historical use and misuse.
About Us
The Ketamine Taskforce was founded by a small group of patients, physicians, certified registered nurse anesthetists, and nurse practitioners who recognized the need for insurance coverage of ketamine treatments for mental health and pain conditions. The Taskforce is dedicated to advocating on behalf of patients everywhere who could benefit from these therapies.
No one should be denied access to medical treatments with the potential to save their life. In support of this mission, the Taskforce has expanded its efforts to include research studies validating the efficacy of these treatments. Our team remains committed to addressing the stigma surrounding ketamine and other psychedelic medicines as they continue to gain legal recognition.
The Taskforce has grown through the dedication of volunteers who believe in our mission. We welcome all individuals who wish to contribute their time and skills to help further our cause.
Insurance and Medicare Coverage of Ketamine Treatments
The Taskforce has held several meetings with local Medicare management companies. They have indicated that research on the senior population remains limited, and that approval will require documented proof of safety and efficacy for individuals over the age of 65. We have designed a study to address this gap but currently lack the funding needed to move forward.
We welcome your support in helping us bring this research to life.